Tubeless Insulin Pump Market: By Component (Pod/Patch, Accessories, and Remote), By Distribution Channel (Hospitals, Pharmacies, Ecommerce, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 – 2029

                                          
Abstract
                    
The global tubeless insulin pump market was estimated at 600 (USD Million) in 2019 and is projected to grow at a CAGR of over 23.5% during the period from 2019 to 2025. The report offers valuation and analysis of Tubeless Insulin Pump Market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, revenue estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Million).

Insulin pump which is also referred to as continuous subcutaneous insulin infusion is rapidly gaining popularity across the medical device industry. This medical device makes use of near-physiologic basal-bolus procedure for delivery of insulin and it is flexible as well as lifestyle-friendly method.


Moreover, tubeless insulin pumps are tiny, unobtrusive, and lightweight in nature and are also refereed as insulin patch pumps. These products are discrete, cost-effective, easily adhere to human body, and easy to use. As per NCBI, patients having type 1 diabetes prefer tubeless insulin pumps. Currently, these pumps make use of Nitinol Wire, Spring, Step Motor, Piezoelectric crystal, Manual pumping chamber, and bladder for insulin delivery. These tubeless insulin pumps are available in myriad sizes and technologies.  These products can be worn and effectively handled under clothing.

Various players developed tubeless insulin pumps and received approval for product promotion from regulatory authorities like U.S. FDA across the United States of America. For instance, Solo™ MicroPump Insulin Delivery System and Finesse™ were the products that received the approval from the U.S. FDA authorities for marketing purpose in year 2010. For the record, OmniPod® Insulin Management System developed by Insulet Corporation was first tubeless insulin pump advertised in the U.S.

Key Growth Drivers

Tube insulin pumps help in both bolus as well as basal rate of insulin delivery. These products help in minimizing the glycemic variability and facilitate in bringing an improvement in glycemic control. All these factors will steer the growth of the tubeless insulin pump industry over the forecast period.  

Furthermore, the product reduces the risk of hypoglycemia and the requirement for medical care. This has lowered the medical care costs and optimized the utility of healthcare resources. Reportedly, clinical trials and observations have displayed progression in long-term glycemic control over routine multiple-dose insulin injections.  Apart from this, the use of tubeless insulin pumps has brought an improvement in the quality of life measures as compared to multiple-dose insulin injections. Rise in diabetics across globe will define the business growth in the near future. Addition of new products to the product line and constant addition of new features to the existing products will boost the market trends and enlarge the scope of the market over the coming years.

Remote Tubeless Insulin Pump Market To Register Highest Gains Over 2019-2025

The remote tubeless insulin pump business is slated to record a highest CAGR of nearly 23% during the forecast period. The growth is attributed to huge acceptance of the component for preventing pain during insulin delivery. Also, growing demand for the remote tubeless insulin pumps is likely owing to rise in the persons affected due to type 1 diabetes.

Ecommerce Segment To Dominate Distribution Channel Segment By 2025

The segmental growth during the forecast period is credited to huge online distribution product offers to increase the sales of the tubeless insulin pumps for the diabetics. Apart from this, rise in the internet penetration across the globe will further impel the growth of the segment over the forthcoming years. Thriving eCommerce sector in the countries like the U.S. is expected to open new horizons of growth for the tubeless insulin market over the foreseeable future.

North American Market To Accrue Huge Revenue Over The Forecast Period

Rise in the diabetic populace in the countries like the U.S. and Canada along with presence of established players in the region will prompt the regional market growth over the forecast timespan.

Moreover, rise in the occurrence of type1 and type2 diabetes in Europe will prop up the market growth in the region over the forecast period.

Key players involved in the tubeless insulin pump business and profiled in the report include Roche Holdings, CeQur, Cellnova, Debiotech, Valeritas Holding, Medtrum Technologies, Spring Health Solutions, Insulet Corporation and Abbott.

The global tubeless insulin pump market can be segmented as follows:

By Component

	
	Pod/Patch
	
	
	Remote
	
	
	Accessories (reservoirs, batteries, etc.)
	

By Distribution Channel

	
	Hospitals
	
	
	Pharmacies
	
	
	E-commerce
	

By Region

	North America
	
		U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa